Hyperinflammation in COVID-19 Obese Patients Treated With Tocilizumab: A Successful Case Series

• Main Authors: Beatriz Amorim Beltrão RN, PhD (Author), Rafael Cabral Teixeira MD (Author), Diego Bastos Porto MD, MSc (Author)
• Format: Book
• Published: SAGE Publishing, 2021-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The cytokine storm syndrome has been suggested as a mechanism in the pathophysiology of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2; COVID-19 [coronavirus disease 2019]) infection. Drugs such as tocilizumab, an interleukin-6 antagonist, have shown good results in other scenarios of h...